Open AccessPD43-10 HOW OFTEN DOES CISPLATIN INELIGIBILITY PREVENT PATIENTS FROM RECEIVING ADJUVANT THERAPY FOLLOWING RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA?
Author(s) -
Kathleen Puttmann,
Alicia Scimeca,
Shawn Dason
Publication year - 2021
Publication title -
the journal of urology/the journal of urology
Language(s) - English
Resource type - Journals
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1097/ju.0000000000002057.10
Subject(s) - medicine , cisplatin , urology , urothelial carcinoma , chemotherapy , transitional cell carcinoma , adjuvant therapy , oncology , surgery , cancer , bladder cancer